The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of the diabetes related diseases.
WONG, SHAN S.;GLOWACKA, DANUTA;JOHNSON, DENNIS R., J. LABELL. COMPOUNDS AND RADIOPHARM., 28,(1990) N, C. 395-403
作者:WONG, SHAN S.、GLOWACKA, DANUTA、JOHNSON, DENNIS R.
DOI:——
日期:——
PROTEINS IN TYPE 2 DIABETES
申请人:Pride Proteomics A/S
公开号:EP1430155A2
公开(公告)日:2004-06-23
IMPROVEMENTS IN OR RELATING TO VIABILITY
申请人:UNIVERSITY OF DURHAM
公开号:EP1608772A1
公开(公告)日:2005-12-28
Viability
申请人:Slabas Ryszard Antoni
公开号:US20060265776A1
公开(公告)日:2006-11-23
Disclosed is a method of killing a plant cell or plant cells by activating a cell death pathway, which pathway is activatable by depletion of extracellular NTP, especially ATP, available to the cell for hydrolysis by cellular NTPase (especially ATPase) enzymes.